CNTA (STOCKS)
Centessa Pharmaceuticals plc American Depositary Shares
$23.560000
+0.010000 (+0.04%)
Prev close: $23.550000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Mario Alberto Accardi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,176.40M
- Employees
- 114
- P/E (TTM)
- -12.94
- P/B (TTM)
- 10.50
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $15.00M |
| Operating Income/Loss | -$213.80M |
| Income/Loss From Continuing Operations After Tax | -$242.70M |
| Income/Loss From Continuing Operations Before Tax | -$239.31M |
| Income Tax Expense/Benefit | $3.39M |
| Income Tax Expense/Benefit, Deferred | $2.67M |
| Net Income/Loss | -$242.70M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$242.70M |
| Net Income/Loss Available To Common Stockholders, Basic | -$242.70M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.89 |
| Diluted Earnings Per Share | -$1.89 |
| Basic Average Shares | 139,528,750 |
| Diluted Average Shares | 139,528,750 |
| Assets | $448.30M |
| Current Assets | $307.68M |
| Noncurrent Assets | $140.63M |
| Fixed Assets | $894.00K |
| Other Non-current Assets | $139.73M |
| Liabilities | $146.73M |
| Current Liabilities | $29.12M |
| Accounts Payable | $8.68M |
| Wages | $5.95M |
| Other Current Liabilities | $14.49M |
| Noncurrent Liabilities | $117.60M |
| Long-term Debt | $109.82M |
| Other Non-current Liabilities | $7.79M |
| Equity | $301.57M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $301.57M |
| Liabilities And Equity | $448.30M |
| Net Cash Flow From Operating Activities | -$180.81M |
| Net Cash Flow From Operating Activities, Continuing | -$180.81M |
| Net Cash Flow From Investing Activities | -$175.40M |
| Net Cash Flow From Investing Activities, Continuing | -$175.40M |
| Net Cash Flow From Financing Activities | $11.09M |
| Net Cash Flow From Financing Activities, Continuing | $11.09M |
| Exchange Gains/Losses | $901.00K |
| Net Cash Flow | -$344.22M |
| Net Cash Flow, Continuing | -$345.12M |
| Comprehensive Income/Loss | -$242.19M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$242.19M |
| Other Comprehensive Income/Loss | -$242.19M |
| Other Comprehensive Income/Loss Attributable To Parent | $505.00K |